Literature DB >> 20849003

How to reduce morbidity and mortality from chest infections in rheumatoid arthritis.

M M Housden1, G Bell, C R Heycock, J Hamilton, V Saravanan, C A Kelly.   

Abstract

Morbidity and mortality from pneumonia is increased in patients with rheumatoid arthritis. Factors contributing to this have been recently identified and a number of recommendations have been implemented in an attempt to reverse this trend. The present paper shows that these measures have combined to produce a fourfold reduction in both admissions and case fatality rates. In the study population, immunisation rates against influenza and pneumococcus have improved to 86% and 65%, oral steroid consumption has halved and disease modifying drugs were usually appropriately suspended during acute infection. These measures may now merit more widespread adoption.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20849003      PMCID: PMC4952158          DOI: 10.7861/clinmedicine.10-4-326

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  4 in total

1.  Urinary tract infections in patients with rheumatoid arthritis.

Authors:  D Puntis; S Malik; V Saravanan; M Rynne; C Heycock; J Hamilton; C A Kelly
Journal:  Clin Rheumatol       Date:  2012-12-14       Impact factor: 2.980

2.  A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK.

Authors:  Sujith Subesinghe; Andrew Ian Rutherford; Fowzia Ibrahim; Helen Harris; James Galloway
Journal:  BMC Musculoskelet Disord       Date:  2016-08-04       Impact factor: 2.362

3.  Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study.

Authors:  William A Blumentals; Anna Arreglado; Pavel Napalkov; Stephen Toovey
Journal:  BMC Musculoskelet Disord       Date:  2012-08-27       Impact factor: 2.362

4.  Association of circulating levels of MMP-8 with mortality from respiratory disease in patients with rheumatoid arthritis.

Authors:  Derek L Mattey; Nicola B Nixon; Peter T Dawes
Journal:  Arthritis Res Ther       Date:  2012-10-02       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.